Table: Kyorin Pharmaceutical -Q1 group results

Kyorin Pharmaceutical

31/07/2024 07:02

Jul 31 (Reuters)- 
             Kyorin Pharmaceutical Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             28.42               27.85           123.40    
                 (+2.0 pct)          (+13.1 pct)      (+3.2 pct)  
  Operating          1.15              871 mln            6.50    
                 (+32.0 pct)                          (+4.3 pct)  
  Recurring          1.42                1.07             6.90    
                 (+32.0 pct)                          (+1.1 pct)  
  Net              885 mln             787 mln            5.00    
                 (+12.4 pct)                          (-8.7 pct)  
  EPS             15.42 yen           13.75 yen        87.03 yen  
  Ann Div                             52.00 yen        52.00 yen  
  -Q2 div                             20.00 yen        20.00 yen  
  -Q4 div                             32.00 yen        32.00 yen  
  
  NOTE - Kyorin Pharmaceutical Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T